Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 765

1.

Use of personalised risk-based screening schedules to optimise workload and sojourn time in screening programmes for diabetic retinopathy: A retrospective cohort study.

Ochs A, McGurnaghan S, Black MW, Leese GP, Philip S, Sattar N, Styles C, Wild SH, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group and the Diabetic Retinopathy Screening Collaborative.

PLoS Med. 2019 Oct 17;16(10):e1002945. doi: 10.1371/journal.pmed.1002945. eCollection 2019 Oct.

2.

Research digest: new horizons in heart failure therapy.

Sattar N, Preiss D.

Lancet Diabetes Endocrinol. 2019 Nov;7(11):832. doi: 10.1016/S2213-8587(19)30315-8. No abstract available.

PMID:
31621593
3.

Response by Sattar et al to Letters Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".

Sattar N, Rawshani A, Franzen S.

Circulation. 2019 Oct 15;140(16):e724-e725. doi: 10.1161/CIRCULATIONAHA.119.042457. Epub 2019 Oct 14. No abstract available.

PMID:
31609663
4.

Determinants of Intima-Media Thickness in the Young: The ALSPAC Study.

Chiesa ST, Charakida M, Georgiopoulos G, Dangardt F, Wade KH, Rapala A, Bhowruth DJ, Nguyen HC, Muthurangu V, Shroff R, Davey Smith G, Lawlor DA, Sattar N, Timpson NJ, Hughes AD, Deanfield JE.

JACC Cardiovasc Imaging. 2019 Oct 11. pii: S1936-878X(19)30875-7. doi: 10.1016/j.jcmg.2019.08.026. [Epub ahead of print]

5.

Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.

Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, Mosseveld M, Avillach P, Egger P, Dhalwani NN, Kendrick S, Celis-Morales C, Waterworth DM, Alazawi W, Sattar N.

BMJ. 2019 Oct 8;367:l5367. doi: 10.1136/bmj.l5367.

6.

Knowledge and Beliefs Regarding Thalassemia in an Urban Population.

Ebrahim S, Raza AZ, Hussain M, Khan A, Kumari L, Rasheed R, Mahmood S, Khatri MA, Bijoora M, Zaheer R, Sattar N, Sohail W, Zakir H, Jafry FH, Memon A, Anwer S, Fatima K.

Cureus. 2019 Jul 29;11(7):e5268. doi: 10.7759/cureus.5268.

7.

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group .

Eur Heart J. 2019 Aug 31. pii: ehz486. doi: 10.1093/eurheartj/ehz486. [Epub ahead of print] No abstract available.

PMID:
31497854
8.

Population-based secular trends in lower-extremity amputation for diabetes and peripheral artery disease.

Hussain MA, Al-Omran M, Salata K, Sivaswamy A, Forbes TL, Sattar N, Aljabri B, Kayssi A, Verma S, de Mestral C.

CMAJ. 2019 Sep 3;191(35):E955-E961. doi: 10.1503/cmaj.190134.

9.

Correction to: Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register.

Steinarsson AO, Rawshani A, Gudbjörnsdottir S, Franzén S, Svensson AM, Sattar N.

Diabetologia. 2019 Sep 2. doi: 10.1007/s00125-019-04992-w. [Epub ahead of print]

PMID:
31478082
10.

Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.

Giles JT, Sattar N, Gabriel S, Ridker PM, Gay S, Warne C, Musselman D, Brockwell L, Shittu E, Klearman M, Fleming TR.

Arthritis Rheumatol. 2019 Aug 30. doi: 10.1002/art.41095. [Epub ahead of print]

PMID:
31469238
11.

Menopausal hot flashing and endothelial function in two vascular beds: findings from a cross-sectional study of postmenopausal women.

Iliodromiti S, Sattar N, Delles C, Nelson SM, Gill JMR, Lumsden M.

Menopause. 2019 Sep;26(9):1002-1009. doi: 10.1097/GME.0000000000001386.

PMID:
31453962
12.

A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals.

Deelen J, Kettunen J, Fischer K, van der Spek A, Trompet S, Kastenmüller G, Boyd A, Zierer J, van den Akker EB, Ala-Korpela M, Amin N, Demirkan A, Ghanbari M, van Heemst D, Ikram MA, van Klinken JB, Mooijaart SP, Peters A, Salomaa V, Sattar N, Spector TD, Tiemeier H, Verhoeven A, Waldenberger M, Würtz P, Davey Smith G, Metspalu A, Perola M, Menni C, Geleijnse JM, Drenos F, Beekman M, Jukema JW, van Duijn CM, Slagboom PE.

Nat Commun. 2019 Aug 20;10(1):3346. doi: 10.1038/s41467-019-11311-9.

13.

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

Kristensen SL, Rørth R, Jhund PS, Docherty KF, Sattar N, Preiss D, Køber L, Petrie MC, McMurray JJV.

Lancet Diabetes Endocrinol. 2019 Oct;7(10):776-785. doi: 10.1016/S2213-8587(19)30249-9. Epub 2019 Aug 14.

PMID:
31422062
14.

Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al.

Agca R, Heslinga SC, Rollefstad S, Heslinga S, Södergren A, Semb AG, Kitas GD, Sattar N, Nurmohamed MT; EULAR task force “EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update”.

Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215748. doi: 10.1136/annrheumdis-2019-215748. [Epub ahead of print] No abstract available.

PMID:
31413003
15.

Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials.

Lim S, Oh TJ, Dawson J, Sattar N.

Diabetes Obes Metab. 2019 Aug 5. doi: 10.1111/dom.13850. [Epub ahead of print] Review.

PMID:
31379119
16.

Sex differences in the association of risk factors for heart failure incidence and mortality.

Sillars A, Ho FK, Pell GP, Gill JMR, Sattar N, Gray S, Celis-Morales C.

Heart. 2019 Jul 31. pii: heartjnl-2019-314878. doi: 10.1136/heartjnl-2019-314878. [Epub ahead of print]

PMID:
31366573
17.

Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence.

Lee MMY, Sattar N, McMurray JJV, Packard CJ.

Curr Atheroscler Rep. 2019 Jul 27;21(10):41. doi: 10.1007/s11883-019-0800-z. Review.

18.

Morning plasma cortisol as a cardiovascular risk factor: findings from prospective cohort and Mendelian randomization studies.

Crawford AA, Söderberg S, Kirschbaum C, Murphy L, Eliasson M, Ebrahim S, Davey Smith G, Olsson T, Sattar N, Lawlor DA, Timpson NJ, Reynolds RM, Walker BR.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0161.R1. doi: 10.1530/EJE-19-0161. [Epub ahead of print]

19.

Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions.

Ferguson LD, Siebert S, McInnes IB, Sattar N.

Nat Rev Rheumatol. 2019 Aug;15(8):461-474. doi: 10.1038/s41584-019-0256-0. Epub 2019 Jul 10. Review.

PMID:
31292564
20.

Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction.

Tromp J, Lim SL, Tay WT, Teng TK, Chandramouli C, Ouwerkerk W, Wander GS, Sawhney JPS, Yap J, MacDonald MR, Ling LH, Sattar N, McMurray JJV, Richards AM, Anand I, Lam CSP; ASIAN-HF Investigators.

Diabetes Care. 2019 Sep;42(9):1792-1799. doi: 10.2337/dc18-2515. Epub 2019 Jul 10.

PMID:
31292141
21.

Diabetes management gains: teaching old dogs new tricks.

Sattar N.

Diabet Med. 2019 Sep;36(9):1072-1074. doi: 10.1111/dme.14068. Epub 2019 Aug 1. No abstract available.

PMID:
31271670
22.

Response by Welsh et al to Letter Regarding Article "Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease".

Welsh CE, Welsh P, Jhund P, Sattar N, Mark PB.

Hypertension. 2019 Aug;74(2):e27-e28. doi: 10.1161/HYPERTENSIONAHA.119.13349. Epub 2019 Jun 24. No abstract available.

PMID:
31230548
23.

Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.

Welsh C, Celis-Morales CA, Brown R, Mackay DF, Lewsey J, Mark PB, Gray SR, Ferguson LD, Anderson JJ, Lyall DM, Cleland JG, Jhund PS, Gill JMR, Pell JP, Sattar N, Welsh P.

Circulation. 2019 Aug 13;140(7):542-552. doi: 10.1161/CIRCULATIONAHA.119.041149. Epub 2019 Jun 20.

24.

The association of grip strength with health outcomes does not differ if grip strength is used in absolute or relative terms: a prospective cohort study.

Ho FKW, Celis-Morales CA, Petermann-Rocha F, Sillars A, Welsh P, Welsh C, Anderson J, Lyall DM, Mackay DF, Sattar N, Gill JMR, Pell JP, Gray SR.

Age Ageing. 2019 Jun 17. pii: afz068. doi: 10.1093/ageing/afz068. [Epub ahead of print]

PMID:
31204772
25.

Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials.

Jenum AK, Brekke I, Mdala I, Muilwijk M, Ramachandran A, Kjøllesdal M, Andersen E, Richardsen KR, Douglas A, Cezard G, Sheikh A, Celis-Morales CA, Gill JMR, Sattar N, Bhopal RS, Beune E, Stronks K, Vandvik PO, van Valkengoed IGM.

Diabetologia. 2019 Aug;62(8):1337-1348. doi: 10.1007/s00125-019-4905-2. Epub 2019 Jun 15. Review.

PMID:
31201437
26.

Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction.

Maznyczka AM, Carrick D, Carberry J, Mangion K, McEntegart M, Petrie MC, Eteiba H, Lindsay M, Hood S, Watkins S, Davie A, Mahrous A, Ford I, Welsh P, Sattar N, Oldroyd KG, Berry C.

Open Heart. 2019 Apr 29;6(1):e000979. doi: 10.1136/openhrt-2018-000979. eCollection 2019.

27.

Do physical activity, commuting mode, cardiorespiratory fitness and sedentary behaviours modify the genetic predisposition to higher BMI? Findings from a UK Biobank study.

Celis-Morales CA, Lyall DM, Petermann F, Anderson J, Ward J, Iliodromiti S, Mackay DF, Welsh P, Bailey MES, Pell J, Sattar N, Gill JMR, Gray SR.

Int J Obes (Lond). 2019 Aug;43(8):1526-1538. doi: 10.1038/s41366-019-0381-5. Epub 2019 Jun 5.

PMID:
31168053
28.

Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, Young KL, Alfred T, Feitosa MF, Masca NGD, Manning AK, Medina-Gomez C, Mudgal P, Ng MCY, Reiner AP, Vedantam S, Willems SM, Winkler TW, Abecasis G, Aben KK, Alam DS, Alharthi SE, Allison M, Amouyel P, Asselbergs FW, Auer PL, Balkau B, Bang LE, Barroso I, Bastarache L, Benn M, Bergmann S, Bielak LF, Blüher M, Boehnke M, Boeing H, Boerwinkle E, Böger CA, Bork-Jensen J, Bots ML, Bottinger EP, Bowden DW, Brandslund I, Breen G, Brilliant MH, Broer L, Brumat M, Burt AA, Butterworth AS, Campbell PT, Cappellani S, Carey DJ, Catamo E, Caulfield MJ, Chambers JC, Chasman DI, Chen YI, Chowdhury R, Christensen C, Chu AY, Cocca M, Collins FS, Cook JP, Corley J, Galbany JC, Cox AJ, Crosslin DS, Cuellar-Partida G, D'Eustacchio A, Danesh J, Davies G, Bakker PIW, Groot MCH, Mutsert R, Deary IJ, Dedoussis G, Demerath EW, Heijer M, Hollander AI, Ruijter HM, Dennis JG, Denny JC, Di Angelantonio E, Drenos F, Du M, Dubé MP, Dunning AM, Easton DF, Edwards TL, Ellinghaus D, Ellinor PT, Elliott P, Evangelou E, Farmaki AE, Farooqi IS, Faul JD, Fauser S, Feng S, Ferrannini E, Ferrieres J, Florez JC, Ford I, Fornage M, Franco OH, Franke A, Franks PW, Friedrich N, Frikke-Schmidt R, Galesloot TE, Gan W, Gandin I, Gasparini P, Gibson J, Giedraitis V, Gjesing AP, Gordon-Larsen P, Gorski M, Grabe HJ, Grant SFA, Grarup N, Griffiths HL, Grove ML, Gudnason V, Gustafsson S, Haessler J, Hakonarson H, Hammerschlag AR, Hansen T, Harris KM, Harris TB, Hattersley AT, Have CT, Hayward C, He L, Heard-Costa NL, Heath AC, Heid IM, Helgeland Ø, Hernesniemi J, Hewitt AW, Holmen OL, Hovingh GK, Howson JMM, Hu Y, Huang PL, Huffman JE, Ikram MA, Ingelsson E, Jackson AU, Jansson JH, Jarvik GP, Jensen GB, Jia Y, Johansson S, Jørgensen ME, Jørgensen T, Jukema JW, Kahali B, Kahn RS, Kähönen M, Kamstrup PR, Kanoni S, Kaprio J, Karaleftheri M, Kardia SLR, Karpe F, Kathiresan S, Kee F, Kiemeney LA, Kim E, Kitajima H, Komulainen P, Kooner JS, Kooperberg C, Korhonen T, Kovacs P, Kuivaniemi H, Kutalik Z, Kuulasmaa K, Kuusisto J, Laakso M, Lakka TA, Lamparter D, Lange EM, Lange LA, Langenberg C, Larson EB, Lee NR, Lehtimäki T, Lewis CE, Li H, Li J, Li-Gao R, Lin H, Lin KH, Lin LA, Lin X, Lind L, Lindström J, Linneberg A, Liu CT, Liu DJ, Liu Y, Lo KS, Lophatananon A, Lotery AJ, Loukola A, Luan J, Lubitz SA, Lyytikäinen LP, Männistö S, Marenne G, Mazul AL, McCarthy MI, McKean-Cowdin R, Medland SE, Meidtner K, Milani L, Mistry V, Mitchell P, Mohlke KL, Moilanen L, Moitry M, Montgomery GW, Mook-Kanamori DO, Moore C, Mori TA, Morris AD, Morris AP, Müller-Nurasyid M, Munroe PB, Nalls MA, Narisu N, Nelson CP, Neville M, Nielsen SF, Nikus K, Njølstad PR, Nordestgaard BG, Nyholt DR, O'Connel JR, O'Donoghue ML, Loohuis LMO, Ophoff RA, Owen KR, Packard CJ, Padmanabhan S, Palmer CNA, Palmer ND, Pasterkamp G, Patel AP, Pattie A, Pedersen O, Peissig PL, Peloso GM, Pennell CE, Perola M, Perry JA, Perry JRB, Pers TH, Person TN, Peters A, Petersen ERB, Peyser PA, Pirie A, Polasek O, Polderman TJ, Puolijoki H, Raitakari OT, Rasheed A, Rauramaa R, Reilly DF, Renström F, Rheinberger M, Ridker PM, Rioux JD, Rivas MA, Roberts DJ, Robertson NR, Robino A, Rolandsson O, Rudan I, Ruth KS, Saleheen D, Salomaa V, Samani NJ, Sapkota Y, Sattar N, Schoen RE, Schreiner PJ, Schulze MB, Scott RA, Segura-Lepe MP, Shah SH, Sheu WH, Sim X, Slater AJ, Small KS, Smith AV, Southam L, Spector TD, Speliotes EK, Starr JM, Stefansson K, Steinthorsdottir V, Stirrups KE, Strauch K, Stringham HM, Stumvoll M, Sun L, Surendran P, Swift AJ, Tada H, Tansey KE, Tardif JC, Taylor KD, Teumer A, Thompson DJ, Thorleifsson G, Thorsteinsdottir U, Thuesen BH, Tönjes A, Tromp G, Trompet S, Tsafantakis E, Tuomilehto J, Tybjaerg-Hansen A, Tyrer JP, Uher R, Uitterlinden AG, Uusitupa M, Laan SW, Duijn CM, Leeuwen N, van Setten J, Vanhala M, Varbo A, Varga TV, Varma R, Edwards DRV, Vermeulen SH, Veronesi G, Vestergaard H, Vitart V, Vogt TF, Völker U, Vuckovic D, Wagenknecht LE, Walker M, Wallentin L, Wang F, Wang CA, Wang S, Wang Y, Ware EB, Wareham NJ, Warren HR, Waterworth DM, Wessel J, White HD, Willer CJ, Wilson JG, Witte DR, Wood AR, Wu Y, Yaghootkar H, Yao J, Yao P, Yerges-Armstrong LM, Young R, Zeggini E, Zhan X, Zhang W, Zhao JH, Zhao W, Zhao W, Zhou W, Zondervan KT; CHD Exome+ Consortium; EPIC-CVD Consortium; ExomeBP Consortium; Global Lipids Genetic Consortium; GoT2D Genes Consortium; EPIC InterAct Consortium; INTERVAL Study; ReproGen Consortium; T2D-Genes Consortium; MAGIC Investigators; Understanding Society Scientific Group, Rotter JI, Pospisilik JA, Rivadeneira F, Borecki IB, Deloukas P, Frayling TM, Lettre G, North KE, Lindgren CM, Hirschhorn JN, Loos RJF.

Nat Genet. 2019 Jul;51(7):1191-1192. doi: 10.1038/s41588-019-0447-2.

29.

Higher Body Mass Index in Adolescence Predicts Cardiomyopathy Risk in Midlife.

Robertson J, Schaufelberger M, Lindgren M, Adiels M, Schiöler L, Torén K, McMurray J, Sattar N, Åberg M, Rosengren A.

Circulation. 2019 Jul 9;140(2):117-125. doi: 10.1161/CIRCULATIONAHA.118.039132. Epub 2019 May 28.

30.

Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank.

Ferguson LD, Brown R, Celis-Morales C, Welsh P, Lyall DM, Pell JP, McInnes IB, Siebert S, Sattar N.

Rheumatology (Oxford). 2019 May 25. pii: kez192. doi: 10.1093/rheumatology/kez192. [Epub ahead of print]

PMID:
31131407
31.

Epidemiology, risk factors, and opportunities for prevention of cardiovascular disease in individuals of South Asian ethnicity living in Europe.

Cainzos-Achirica M, Fedeli U, Sattar N, Agyemang C, Jenum AK, McEvoy JW, Murphy JD, Brotons C, Elosua R, Bilal U, Kanaya AM, Kandula NR, Martinez-Amezcua P, Comin-Colet J, Pinto X.

Atherosclerosis. 2019 Jul;286:105-113. doi: 10.1016/j.atherosclerosis.2019.05.014. Epub 2019 May 16. Review.

PMID:
31128454
32.

Association between fat mass through adolescence and arterial stiffness: a population-based study from The Avon Longitudinal Study of Parents and Children.

Dangardt F, Charakida M, Georgiopoulos G, Chiesa ST, Rapala A, Wade KH, Hughes AD, Timpson NJ, Pateras K, Finer N, Sattar N, Davey Smith G, Lawlor DA, Deanfield JE.

Lancet Child Adolesc Health. 2019 Jul;3(7):474-481. doi: 10.1016/S2352-4642(19)30105-1. Epub 2019 May 21.

33.

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.

Alexander M, Loomis AK, van der Lei J, Duarte-Salles T, Prieto-Alhambra D, Ansell D, Pasqua A, Lapi F, Rijnbeek P, Mosseveld M, Waterworth DM, Kendrick S, Sattar N, Alazawi W.

BMC Med. 2019 May 20;17(1):95. doi: 10.1186/s12916-019-1321-x.

34.

Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.

Ferreira JP, Verdonschot J, Collier T, Wang P, Pizard A, Bär C, Björkman J, Boccanelli A, Butler J, Clark A, Cleland JG, Delles C, Diez J, Girerd N, González A, Hazebroek M, Huby AC, Jukema W, Latini R, Leenders J, Levy D, Mebazaa A, Mischak H, Pinet F, Rossignol P, Sattar N, Sever P, Staessen JA, Thum T, Vodovar N, Zhang ZY, Heymans S, Zannad F.

Circ Heart Fail. 2019 May;12(5):e005897. doi: 10.1161/CIRCHEARTFAILURE.118.005897.

PMID:
31104495
35.

Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016.

Mair C, Wulaningsih W, Jeyam A, McGurnaghan S, Blackbourn L, Kennon B, Leese G, Lindsay R, McCrimmon RJ, McKnight J, Petrie JR, Sattar N, Wild SH, Conway N, Craigie I, Robertson K, Bath L, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network (SDRN) Epidemiology Group.

Diabetologia. 2019 Aug;62(8):1375-1384. doi: 10.1007/s00125-019-4900-7. Epub 2019 May 18.

36.

Research digest: SGLT2 inhibition in kidney and liver disease.

Preiss D, Sattar N.

Lancet Diabetes Endocrinol. 2019 Jun;7(6):427. doi: 10.1016/S2213-8587(19)30160-3. No abstract available.

PMID:
31103176
37.

Understanding the mechanisms of reversal of type 2 diabetes.

Taylor R, Al-Mrabeh A, Sattar N.

Lancet Diabetes Endocrinol. 2019 Sep;7(9):726-736. doi: 10.1016/S2213-8587(19)30076-2. Epub 2019 May 13. Review. Erratum in: Lancet Diabetes Endocrinol. 2019 May 22;:.

PMID:
31097391
38.

Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.

Ward-Caviness CK, de Vries PS, Wiggins KL, Huffman JE, Yanek LR, Bielak LF, Giulianini F, Guo X, Kleber ME, Kacprowski T, Groß S, Petersman A, Davey Smith G, Hartwig FP, Bowden J, Hemani G, Müller-Nuraysid M, Strauch K, Koenig W, Waldenberger M, Meitinger T, Pankratz N, Boerwinkle E, Tang W, Fu YP, Johnson AD, Song C, de Maat MPM, Uitterlinden AG, Franco OH, Brody JA, McKnight B, Chen YI, Psaty BM, Mathias RA, Becker DM, Peyser PA, Smith JA, Bielinski SJ, Ridker PM, Taylor KD, Yao J, Tracy R, Delgado G, Trompet S, Sattar N, Jukema JW, Becker LC, Kardia SLR, Rotter JI, März W, Dörr M, Chasman DI, Dehghan A, O'Donnell CJ, Smith NL, Peters A, Morrison AC.

PLoS One. 2019 May 10;14(5):e0216222. doi: 10.1371/journal.pone.0216222. eCollection 2019.

39.

Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease.

Welsh CE, Welsh P, Jhund P, Delles C, Celis-Morales C, Lewsey JD, Gray S, Lyall D, Iliodromiti S, Gill JMR, Sattar N, Mark PB.

Hypertension. 2019 Jun;73(6):1202-1209. doi: 10.1161/HYPERTENSIONAHA.119.12726.

PMID:
31067194
40.

BMI, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes: Findings Against an Obesity Paradox.

Edqvist J, Rawshani A, Adiels M, Björck L, Lind M, Svensson AM, Gudbjörnsdottir S, Sattar N, Rosengren A.

Diabetes Care. 2019 Jul;42(7):1297-1304. doi: 10.2337/dc18-1446. Epub 2019 May 2.

PMID:
31048408
41.

Da Qing 30 years on: more reasons to extend diabetes prevention.

Lean MEJ, Sattar N.

Lancet Diabetes Endocrinol. 2019 Jun;7(6):417-419. doi: 10.1016/S2213-8587(19)30138-X. Epub 2019 Apr 25. No abstract available. Erratum in: Lancet Diabetes Endocrinol. 2019 Aug;7(8):e20.

PMID:
31031111
42.

Assessing for interaction between APOE ε4, sex, and lifestyle on cognitive abilities.

Lyall DM, Celis-Morales C, Lyall LM, Graham C, Graham N, Mackay DF, Strawbridge RJ, Ward J, Gill JMR, Sattar N, Cavanagh J, Smith DJ, Pell JP.

Neurology. 2019 Jun 4;92(23):e2691-e2698. doi: 10.1212/WNL.0000000000007551. Epub 2019 Apr 26.

43.

Cardiac Troponin T and Troponin I in the General Population.

Welsh P, Preiss D, Hayward C, Shah ASV, McAllister D, Briggs A, Boachie C, McConnachie A, Padmanabhan S, Welsh C, Woodward M, Campbell A, Porteous D, Mills NL, Sattar N.

Circulation. 2019 Jun 11;139(24):2754-2764. doi: 10.1161/CIRCULATIONAHA.118.038529. Epub 2019 Apr 24.

44.

Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies.

Mazidi M, Katsiki N, Mikhailidis DP, Sattar N, Banach M.

Eur Heart J. 2019 Sep 7;40(34):2870-2879. doi: 10.1093/eurheartj/ehz174.

PMID:
31004146
45.

Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus.

Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, Ashcroft DM, Rutter MK.

Circulation. 2019 Jun 11;139(24):2742-2753. doi: 10.1161/CIRCULATIONAHA.118.039100. Epub 2019 Apr 15.

PMID:
30986362
46.

A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.

Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF, Symmons DPM; TRACE RA Consortium.

Arthritis Rheumatol. 2019 Sep;71(9):1437-1449. doi: 10.1002/art.40892. Epub 2019 Jul 22.

47.

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.

Sattar N, Rawshani A, Franzén S, Rawshani A, Svensson AM, Rosengren A, McGuire DK, Eliasson B, Gudbjörnsdottir S.

Circulation. 2019 May 7;139(19):2228-2237. doi: 10.1161/CIRCULATIONAHA.118.037885.

PMID:
30955347
48.

Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity.

Lyall DM, Cox SR, Lyall LM, Celis-Morales C, Cullen B, Mackay DF, Ward J, Strawbridge RJ, McIntosh AM, Sattar N, Smith DJ, Cavanagh J, Deary IJ, Pell JP.

Brain Imaging Behav. 2019 Mar 22. doi: 10.1007/s11682-019-00069-9. [Epub ahead of print]

PMID:
30903549
49.

Research digest: new insights into established risk pathways.

Preiss D, Sattar N.

Lancet Diabetes Endocrinol. 2019 Apr;7(4):254. doi: 10.1016/S2213-8587(19)30091-9. No abstract available.

PMID:
30902265
50.

The Combination of Physical Activity and Sedentary Behaviors Modifies the Genetic Predisposition to Obesity.

Celis-Morales CA, Lyall DM, Bailey MES, Petermann-Rocha F, Anderson J, Ward J, Mackay DF, Welsh P, Pell JP, Sattar N, Gill JMR, Gray SR.

Obesity (Silver Spring). 2019 Apr;27(4):653-661. doi: 10.1002/oby.22417.

PMID:
30900409

Supplemental Content

Loading ...
Support Center